Interventional Neurology Devices Market: By Product Type, By Technology Type, By Indication, By End User and Region Forecast 2021-2032

download arrow download arrow Download Sample
settings arrow settings arrow email us

Interventional Neurology Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Cerebral Balloon Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Aneurysm Coiling and Embolization Devices), By Technology Type (Carotid artery angioplasty and stenting, Vertebroplasty, Stroke therapy, Pre-operative tumour embolization), By Indication (Cerebral aneurysm, Ischemic strokes, Arteriovenous malformations and Fistulas, Others), By End User (Hospitals, Neurology Clinics, Ambulatory surgical centres) and Region Forecast 2021-2032

Report ID:17677

Published Date:Aug 2025

No of Pages:212

Format:

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Interventional Neurology Devices Market size was valued at US$ 2.7 billion in 2025 and is expected to reach US$ 3.8 billion by 2032, growing at a significant CAGR of 5.0% from 2026-2032. Interventional neurology is a speciality which utilizes the minimally invasive procedures with image-guided techniques for the diagnosis and treatment of various chronic neurological diseases related to veins & arteries of neck, brain, and spine. The most commonly treated diseases with interventional neurology include head and neck tumours, ischemic strokes, meningiomas, spinal vascular malformations, cerebral aneurysm, and intracranial atherosclerosis among others. Different types of materials such as cobalt, platinum, and nitinol are used in neurovascular devices for ischemic stroke prevention and aneurysm.

Increase in the global aging population, technological advancements in the interventional neurology devices, a rise in prevalence of ischemic stroke and hemorrhagic conditions, and growing demand for minimally invasive procedures are anticipated to fuel the market. Furthermore, advantages of an interventional procedure such as the minimal possibility of infection and surgical trauma, favourable reimbursement policies, and rise in product development and commercialization are expected to bolster the market over the forecast period. However, stringent regulatory guidelines for the product approvals, a high cost of the treatment, and lack of skilled professionals might impede the growth of the market.

Key Developments

  • In June 2017, DePuy Synthes acquired Sentio, LLC to enable the innovation in minimally invasive surgery of spine In October 2016, St. Jude Medical, Inc. received FDA approval for Amplatzer PFO used in the treatment of recurrent ischemic stroke and launched in U.S. market

summary download arrow Download Sample

Global Interventional Neurology Devices Market Summary

Study Period

2026-2032

Base Year

2025

CAGR

5%

Largest Market

North-America

Fastest Growing Market

North-America

Interventional Neurology Devices Market Dynamics

The market is growing at a significant CAGR owing to increase in the demand for minimally invasive neurological surgical procedures. A rise in the prevalence of neurological disorders (according to World Health Organization, more than 6.8 Mn people are dying from neurological disorders) expected to drive the revenue growth of market. Moreover, a majority of the market players are focusing on the development of novel devices with minimally invasive techniques. Acquisitions and mergers, collaborations, product approvals, and launchings are strategies followed by the companies for dominating the market. For instance, in June 2016, Terumo Corporation acquired Sequent Medical, Inc. for the development of a novel medical device for the aneurysm embolization. Moreover, in January 2012, Covidien received FDA approval for the Solitaire revascularization device interventional management of stroke trial.

Global Interventional Neurology Devices Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2026-2032

Market CAGR

5%

By Product Type

  • Cerebral Balloon Angioplasty and Stenting Systems,
  • Neurothrombectomy Devices,
  • Support Devices,
  • Aneurysm Coiling and
  • Embolization Devices

By Technology

  • Carotid Artery Angioplasty and Stenting
  • Vertebroplasty
  • Stroke Therapy
  • Pre-operative Tumour Embolization

By Indication

  • Cerebral Aneurysm,
  • Ischemic Strokes,
  • Arteriovenous Malformations and Fistulas,
  • Others

By End User

  • Hospitals,
  • Neurology Clinics,
  • Ambulatory Surgical Centres

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The interventional neurology devices market report provides granular level information about the market size, regional market share, historic market (2021-2025), and forecast (2026-2032)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porterâ's Five Force Analysis 

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Interventional Neurology Devices Market size was valued at US$ 2.7 billion in 2025 and is expected to reach US$ 3.8 billion by 2032, growing at a significant CAGR of 5.0% from 2026-2032

The market key players are Medtronic plc) (Ireland), Stryker Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.), Abbott Laboratories (U.S.), Terumo Corporation (Japan), Bayer AG (Germany), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.)

North America is the fastest-growing region for interventional neurology devices market

Content Updated Date: Feb 2026

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Interventional Neurology Devices Market Introduction 
2.1.Global Interventional Neurology Devices Market  - Taxonomy
2.2.Global Interventional Neurology Devices Market  - Definitions
2.2.1.Product Type 
2.2.2.Technology
2.2.3.Indication
2.2.4.End User
2.2.5.Region
3. Global Interventional Neurology Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Interventional Neurology Devices Market Analysis, 2021 - 2025 and Forecast 2026 - 2032
4.1.  Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Interventional Neurology Devices Market  By Product Type , 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
5.1. Cerebral Balloon Angioplasty and Stenting Systems,
5.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Neurothrombectomy Devices,
5.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Support Devices,
5.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Aneurysm Coiling and
5.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Embolization Devices
5.5.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. Global Interventional Neurology Devices Market  By Technology, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
6.1. Carotid Artery Angioplasty and Stenting
6.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Vertebroplasty
6.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Stroke Therapy
6.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Pre-operative Tumour Embolization
6.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Interventional Neurology Devices Market  By Indication, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
7.1. Cerebral Aneurysm,
7.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ischemic Strokes,
7.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Arteriovenous Malformations and Fistulas,
7.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Interventional Neurology Devices Market  By End User, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
8.1. Hospitals,
8.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Neurology Clinics,
8.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Ambulatory Surgical Centres
8.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9. Global Interventional Neurology Devices Market  By Region, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Interventional Neurology Devices Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
10.1. Product Type  Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cerebral Balloon Angioplasty and Stenting Systems,
10.1.2.Neurothrombectomy Devices,
10.1.3.Support Devices,
10.1.4.Aneurysm Coiling and
10.1.5.Embolization Devices
10.2.  Technology Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Carotid Artery Angioplasty and Stenting
10.2.2.Vertebroplasty
10.2.3.Stroke Therapy
10.2.4.Pre-operative Tumour Embolization
10.3.  Indication Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Cerebral Aneurysm,
10.3.2.Ischemic Strokes,
10.3.3.Arteriovenous Malformations and Fistulas,
10.3.4.Others
10.4.  End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals,
10.4.2.Neurology Clinics,
10.4.3.Ambulatory Surgical Centres
10.5.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Interventional Neurology Devices Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cerebral Balloon Angioplasty and Stenting Systems,
11.1.2.Neurothrombectomy Devices,
11.1.3.Support Devices,
11.1.4.Aneurysm Coiling and
11.1.5.Embolization Devices
11.2.  Technology Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Carotid Artery Angioplasty and Stenting
11.2.2.Vertebroplasty
11.2.3.Stroke Therapy
11.2.4.Pre-operative Tumour Embolization
11.3.  Indication Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Cerebral Aneurysm,
11.3.2.Ischemic Strokes,
11.3.3.Arteriovenous Malformations and Fistulas,
11.3.4.Others
11.4.  End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals,
11.4.2.Neurology Clinics,
11.4.3.Ambulatory Surgical Centres
11.5.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Interventional Neurology Devices Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cerebral Balloon Angioplasty and Stenting Systems,
12.1.2.Neurothrombectomy Devices,
12.1.3.Support Devices,
12.1.4.Aneurysm Coiling and
12.1.5.Embolization Devices
12.2.  Technology Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Carotid Artery Angioplasty and Stenting
12.2.2.Vertebroplasty
12.2.3.Stroke Therapy
12.2.4.Pre-operative Tumour Embolization
12.3.  Indication Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Cerebral Aneurysm,
12.3.2.Ischemic Strokes,
12.3.3.Arteriovenous Malformations and Fistulas,
12.3.4.Others
12.4.  End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals,
12.4.2.Neurology Clinics,
12.4.3.Ambulatory Surgical Centres
12.5.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Interventional Neurology Devices Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Cerebral Balloon Angioplasty and Stenting Systems,
13.1.2.Neurothrombectomy Devices,
13.1.3.Support Devices,
13.1.4.Aneurysm Coiling and
13.1.5.Embolization Devices
13.2.  Technology Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Carotid Artery Angioplasty and Stenting
13.2.2.Vertebroplasty
13.2.3.Stroke Therapy
13.2.4.Pre-operative Tumour Embolization
13.3.  Indication Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Cerebral Aneurysm,
13.3.2.Ischemic Strokes,
13.3.3.Arteriovenous Malformations and Fistulas,
13.3.4.Others
13.4.  End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals,
13.4.2.Neurology Clinics,
13.4.3.Ambulatory Surgical Centres
13.5.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Interventional Neurology Devices Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million)
14.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Cerebral Balloon Angioplasty and Stenting Systems,
14.1.2.Neurothrombectomy Devices,
14.1.3.Support Devices,
14.1.4.Aneurysm Coiling and
14.1.5.Embolization Devices
14.2.  Technology Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Carotid Artery Angioplasty and Stenting
14.2.2.Vertebroplasty
14.2.3.Stroke Therapy
14.2.4.Pre-operative Tumour Embolization
14.3.  Indication Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Cerebral Aneurysm,
14.3.2.Ischemic Strokes,
14.3.3.Arteriovenous Malformations and Fistulas,
14.3.4.Others
14.4.  End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals,
14.4.2.Neurology Clinics,
14.4.3.Ambulatory Surgical Centres
14.5.  Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Medtronic plc) (Ireland)
15.2.2.Stryker Corporation (U.S.)
15.2.3.Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.)
15.2.4.Abbott Laboratories (U.S.)
15.2.5.Terumo Corporation (Japan)
15.2.6.Bayer AG (Germany)
15.2.7.Boston Scientific Corporation (U.S.)
15.2.8.Penumbra, Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Medtronic plc) (Ireland)
  • Stryker Corporation (U.S.)
  • Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.)
  • Abbott Laboratories (U.S.)
  • Terumo Corporation (Japan)
  • Bayer AG (Germany)
  • Boston Scientific Corporation (U.S.)
  • Penumbra, Inc. (U.S.)

Related Industry Reports

Transcatheter Embolization Occlusion Devices Market

Global Venous Thromboembolism Devices Market